Key facts
- It has raised $4.5M; the latest was Early Stage VC ($4.5M) in Feb 2025.
- Notable investors include StartLife, Agri Investment Fund, Invest Mons Borinage Centre, Invest.BW, Pymwymic — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Biocsol
- ·The full record, as it builds
Funding rounds
No funding rounds for Biocsol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biocsol
Developer of agricultural biologicals intended for crop protection purposes. The company utilizes a proprietary extraction process to derive specific natural substances from beneficial microorganisms to create stable, microbial-free biopesticides that target fungal pathogens such as mildew in potato and grape cultivation, enabling farmers and agricultural producers to transition away from synthetic chemical inputs while maintaining yield reliability and environmental biodiversity through biodegradable, residue-free chemicals.
- Sector
- Materials and Resources
- HQ
- Ottignies-Louvain-la-Neuve, Belgium
- Founded
- 2023
- Employees
- 7
- Website
- biocsol.com/
- Ownership
- Privately Held (backing)
Biocsol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biocsol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biocsol in its N-PORT filings yet. We sweep new filings monthly.